贝伐珠单抗再利用潜力及其对临床实践影响的研究和试点分析

IF 1.5 4区生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Biotechnology & Biotechnological Equipment Pub Date : 2024-06-22 DOI:10.1080/13102818.2024.2357191

Antonio Ivanov, Violeta Getova-Kolarova, Valentina Belcheva, Evgeni Grigorov, Ilko Getov

引用次数: 0

摘要

药物的再利用是一种为已获授权或已通过测试的药物在其原始适应症之外发现新用途的策略。贝伐珠单抗是一种人源化抗体，据观察具有抗VEGF的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Research and pilot analysis of bevacizumab repurposing potential and its impact in clinical practice

Repurposing of drugs is a strategy for discovering new uses for already authorized or tested medicines outside their original indications. Bevacizumab is humanized antibody, observed to have anti-V...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Biotechnology & Biotechnological Equipment 工程技术-生物工程与应用微生物

CiteScore

3.10

自引率

0.00%

发文量

审稿时长

1 months

期刊介绍： Biotechnology & Biotechnological Equipment (B&BE) is an international open access journal publishing cutting-edge research. A modern world requires modern biotechnology and nanobiology. The journal is a forum that provides society with valuable information for a healthy and better life and promotes “the Science and Culture of Nature”. The journal publishes original research and reviews with a multidisciplinary perspective; expanded case reports with a focus on molecular medical research and advanced practice in evidence-based medicine are also considered.